Abstract
We developed an in vitro method for isolating and expanding autologous CD4+ T-cell clones with specificity for the melanoma-associated antigen NY-ESO-1. We infused these cells into a patient with refractory metastatic melanoma who had not undergone any previous conditioning or cytokine treatment. We show that the transferred CD4+ T cells mediated a durable clinical remission and led to endogenous responses against melanoma antigens other than NY-ESO-1.
| Original language | English |
|---|---|
| Pages (from-to) | 2698-2703 |
| Number of pages | 6 |
| Journal | New England Journal of Medicine |
| Volume | 358 |
| Issue number | 25 |
| DOIs | |
| State | Published - 19 Jun 2008 |
| Externally published | Yes |
Fingerprint
Dive into the research topics of 'Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver